Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Composite end-point of death, constriction, or cardiac tamponade requiring pericardial drainage.
Safety of immunomodulatory treatment
The secondary efficacy outcomes are the individual components of the composite primary outcome (i.e., death, constriction, and cardiac tamponade requiring pericardiocentesis), and all-cause hospitalization.
18 Years and older (Adult, Senior)
December 18, 2008
September 3, 2014
Groote Schuur Hospital Cape Town, Western Cape, South Africa
† Study has passed its completion date and status has not been verified in more than two years.